Hope Medicine

Focus: Hope Medicine is a China-based antibody therapy biotech founded in 2022, headquartered in Pudong with a focus on oncology, neurology, and infectious disease programs.

Neurology Oncology Infectious Diseases Dermatology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Hope Medicine

AI assessmentNot Hiring

No open roles listed right now. Follow Hope Medicine to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

3 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Withou

Amyotrophic Lateral Sclerosis

N/A

Clinical Trials (1)

NCT00718107Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology

N/A

Help build intelligence for Hope Medicine

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage antibody platform with diversified pipeline across 5 therapeutic areas (oncology, neurology, infectious disease, dermatology, women's health)
Access to emerging China biotech market with Pudong headquarters in a major pharma hub
Opportunity to contribute to foundational science at pre-revenue stage with potential for significant equity upside

Watch Out For

Company is extremely early-stage (founded 2022) with no active job openings and unknown employee count, suggesting limited hiring and organizational infrastructure
Pipeline data appears corrupted or improperly curated—many programs lack coherent drug names and clinical trial structure, raising questions about data quality and operational rigor
No disclosed funding, revenue, or financial metrics available; early biotech survival risk is substantial without transparent capitalization details

Generated by Claude from Hope Medicine's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

questionaire, blood or saliva sample

Breast Cancer

N/A

One-time blood

Diabetes

N/A

Clinical Trials (1)

NCT05505669Circulating Biomarkers in the Development of Type 1 Diabetes

N/A

Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral S

Amyotrophic Lateral Sclerosis

N/A

Clinical Trials (1)

NCT00714220Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)

N/A

Gamification and Social Support

Cardiovascular Diseases

N/A

Clinical Trials (1)

NCT05176756RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)

N/A

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the

Amyotrophic Lateral Sclerosis

N/A

Clinical Trials (1)

NCT00718497Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

N/A

Cerebrospinal Fluid Repository

Amyotrophic Lateral Sclerosis

N/A

Clinical Trials (1)

NCT00714636Cerebrospinal Fluid Repository

N/A

Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS

Amyotrophic Lateral Sclerosis

N/A

Clinical Trials (1)

NCT00718003Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).

N/A

Quitbuddy

Tobacco Use Disorder

N/A

Clinical Trials (1)

NCT05625685Equitable Smoking Relapse Prevention

N/A

Biospecimen Collection

Asymptomatic COVID-19 Infection Laboratory-Confirmed

N/A

Clinical Trials (1)

NCT04497779Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

N/A

Blood sampling

Salmonella Septicemia

N/A

Clinical Trials (1)

NCT02689193IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres

N/A

rk28 ICT

Visceral Leishmaniasis

N/A

Clinical Trials (1)

NCT01766830Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

N/A

Data and Specimen Collection

Li-Fraumeni Syndrome

N/A

Clinical Trials (1)

NCT04541654Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

N/A

Confirmatory Testing

Acid Sphingomyelinase Deficiency

N/A

Light Glasses

Cancer-related Problem/Condition